Hydrogen sulfide induced neuronal death occurs via glutamate receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons

Neuropharmacology

Volumn 53, Issue 4, 2007, Pages 505-514

  Cheung, Nam Sang ^a   Peng, Zhao Feng ^a   Chen, Minghui Jessica ^a   Moore, Philip K ^a   Whiteman, Matthew ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Alzheimer's disease; Glutamate; Hydrogen sulfide; Neurodegeneration; Neuronal cell death; NMDA; Stroke

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CALPAIN; DIZOCILPINE; GLUTAMATE RECEPTOR; HYDROGEN SULFIDE; RECEPTOR SUBTYPE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FLUORESCENCE ANALYSIS; INCUBATION TIME; LYSOSOME; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CALPAIN; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYONIC STRUCTURES; ENZYME ACTIVATION; HYDROGEN SULFIDE; INTRACELLULAR MEMBRANES; LYSOSOMES; MICE; NEURONS; RECEPTORS, GLUTAMATE;

EID: 34548022648     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.06.014     Document Type: Article

References (47)

1. Abe K., and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16 (1996) 1066-1071
2. Arundine M., and Tymianski M. Molecular mechanisms of glutamate-dependent neurodeneration in ischaemia and traumatic brain injury. Cell. Mol. Life Sci. 61 (2004) 657-668
3. Bahr B.A., and Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. Neurochemistry 83 (2002) 481-489
4. Beyer K., Lao J.I., Carrato C., Rodriguez-Vila A., Latorre P., Mataro M., Llopis M.A., Mate J.L., and Ariza A. Cystathionine beta synthase as a risk factor for Alzheimer disease. Curr. Alzheimer Res. 1 (2004) 123-127
5. Caba E., Brown Q.B., Kawasaki B., and Bahr B.A. Peptidyl alpha-keto amide inhibitor of calpain blocks excitotoxic damage without affecting signal transduction events. J. Neurosci. Res. 67 (2002) 787-794
6. Carragher N.O. Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr. Pharm. Des. 12 (2006) 615-638
7. Cheung N.S., Pascoe C.J., Giardina S.F., John C.A., and Beart P.M. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones. Neuropharmacology 37 (1998) 1419-1429
8. Cheung N.S., Beart P.M., Pascoe C.J., John C.A., and Bernard O. Human Bcl-2 protects against AMPA receptor-mediated apoptosis. J. Neurochem. 74 (2000) 1613-1620
9. Choi S.H., Choi D.H., Lee J.J., Park M.S., and Chun B.G. Imidazoline drugs stabilize lysosomes and inhibit oxidative cytotoxicity in astrocytes. Free Radic. Biol. Med. 32 (2002) 394-405
10. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55 (1998) 1449-1455
11. Doraiswamy P.M. Alzheimer's disease and the glutamate NMDA receptor. Psychopharm. Bull. 37 (2003) 41-49
12. Graber S., Maiti S., and Halpain S. Cathepsin B-like proteolysis and MARCKS degradation in sub-lethal NMDA-induced collapse of dendritic spines. Neuropharmacology 47 (2004) 706-713
13. Hara M., and Snyder S. Cell signaling and neuronal death. Annu. Rev. Pharmacol Toxicol. 47 (2007) 117-141
14. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45 (2004) 583-593
15. Kamoun P., Belardinelli M.C., Chabli A., Lallouchi K., and Chadefaux-Vekemans B. Endogenous hydrogen sulfide overproduction in Down syndrome. Am. J. Med. Genet. A. 116 (2003) 310-311
16. Kimura H. Hydrogen sulfide as a neuromodulator. Mol. Neurobiol. 26 (2000) 13-19
17. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem. Biophys. Res. Commun. 267 (2000) 129-133
18. Kimura Y., and Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 18 (2004) 1165-1167
19. Lleo A., Greenberg S.M., and Growdon J.H. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57 (2006) 513-533
20. Martin S.J., O'Brien G.A., Nishioka W.K., McGahon A.J., Mahboubi A., Saido T.C., and Green D.R. Proteolysis of fodrin non-erythroid spectrin during apoptosis. J. Biol. Chem. 270 (1995) 6425-6428
21. Milhaud D., Fagni L., Bockaert J., and Lafon-Cazal M. Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures. Neuropharmacology 39 (2000) 2244-2254
22. Moore P.K., Bhatia M., and Moochala S. Hydrogen sulphide: from the smell of the past to the gas of the future?. Trends Pharmacol. Sci. 24 (2003) 609-611
23. Morrison L.D., Smith D.D., and Kish S.J. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J. Neurochem. 67 (1996) 1328-1331
24. Nagai Y., Tsugane M., Oka J., and Kimura H. Hydrogen sulfide induces calcium waves in astrocytes. FASEB J. 18 (2004) 557-559
25. National Research Council of the United States of America, 1979. Committee on Medical and Biologic Effects of Environmental Pollutants, Assembly of Life Sciences, Subcommittee on hydrogen sulfide. National Academy of Sciences, Washington, DC, University Park Press, Baltimore, MD, USA.
26. Navarra P., Dello Russo C., Mancuso C., Preziosi P., and Grossman A. Gaseous neuromodulators in the control of neuroendocrine stress axis. Ann. N.Y. Acad. Sci. 917 (2000) 638-646
27. Nixon R.A., and Cataldo A. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J. Alzheimers Dis. 9 (2006) 277-289
28. Nixon R.A., Cataldo A.M., and Mathews P.M. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem. Res. 25 (2000) 1161-1172
29. Posner A., Raser K.J., Hajimohammadreza I., Yuen P.W., and Wang K.K. Aurintricarboxylic acid is an inhibitor of mu- and m-calpain. Biochem. Mol. Biol. Int. 36 (1995) 291-299
30. Qu K., Chen C.P., Halliwell B., Moore P.K., and Wong P.T. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37 (2006) 889-893
31. Saito K., Elce J.S., Hamos J.E., and Nixon R.A. Widespread activation of calcium-activated neutral proteinase calpain in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA 90 (1993) 2628-2632
32. Scheuer K., Maras A., Gattaz W.F., Cairns N., Forstl H., and Muller W.C. Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. Dementia 7 (1996) 210-214
33. Siman R., Noszek J.C., and Kegerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9 (1989) 1579-1590
34. Simpkins K.L., Guttmann R.P., Dong Y., Chen Z., Sokol S., Neumar R.W., and Lynch D.R. Selective activation induced cleavage of the NR2B subunit by calpain. J. Neurosci. 23 (2003) 11322-11331
35. Tenneti L., D'Emilia D.M., Troy C.M., and Lipton S.A. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 71 (1998) 946-959
36. Traynelis S.F., Hartley M., and Heinemann D.F. Control of proton sensitivity of the NMDA receptor by RNS splicing and polyamines. Science 268 (1995) 776-873
37. US Environmental Protection Agency, June 2003. Toxicological review of hydrogen sulphide. CAS No. 7783-06-4.
38. Whiteman M., Armstrong J.S., Chu S.H., Siau J.-L., Cheung N.S., Halliwell B., and Moore P.K. The novel neuromodulator hydrogen sulphide: an endogenous peroxynitrite 'scavenger'?. J. Neurochem. 90 (2004) 765-768
39. Whiteman M., Armstrong J.S., Cheung N.S., Siau J.-L., Rose P., Schantz J.-T., Jones D.P., and Halliwell B. Peroxynitrite mediates calcium-dependent mitochondrial permeability transition and cell death via activation of calpains. FASEB J. 18 (2004) 1395-1397
40. Whiteman M., Cheung N.S., Zhu Y.-Z., Chu S.H., Siau J.-L., Wong B.S., Armstrong J.S., and Moore P.K. Hydrogen sulphide; a novel inhibitor of hypochlorous acid mediated oxidative damage in the brain?. Biochem. Biophys. Res. Commun. 326 (2005) 779-794
41. Whiteman M., Li L., Kostetski I., Chu S.H., Siau J.-L., Bhatia M., and Moore P.K. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulfide. Biochem. Biophys. Res. Commun. 343 (2006) 303-310
42. Wolf B.B., Goldstein J.C., Stennicke H.R., Beere H., Amarante-Mendes G.P., Salvesen G.S., and Green D.R. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 94 (1999) 1683-1692
43. Yamashima T., Tonchev A.B., Tsukada T., Saido T.C., Imajoh-Ohmi S., Momoi T., and Kominami E. Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 13 (2003) 791-800
44. Yap Y.W., Whiteman M., Bay B.H., Li Y., Sheu F.S., Qi R.Z., Tan C.H., and Cheung N.S. Hypochlorous acid induces apoptosis of cultured cortical neurons through activation of calpains and rupture of lysosomes. J. Neurochem. 98 (2006) 1597-1609
45. Zatz M., and Starling A. Calpains and disease. N. Engl. J. Med. 352 (2005) 2413-2423
46. Zdolsek J.M., Olsson G.M., and Brunk U.T. Photooxidative damage to lysosomes of cultured macrophages by acridine orange. Photochem. Photobiol. 51 (1990) 67
47. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. 283 (2002) H474-H480